clinical trial · NCT06683352
A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People
Influenza,HumanCOVID-19Investigational Influenza VaccineCOVID-19 VaccineInfluenza and COVID Combination VaccineLicensed Influenza Vaccine 1Licensed Influenza Vaccine 2Placebo
brief summary
This study is to learn about flu and COVID vaccines, either alone or when mixed together. Healthy people aged 18 or older can join. Participants will get one shot in each arm, either a flu or COVID vaccine, alone or mixed. The study lasts about 6 months, and participants need to visit the research site at least 3 times.
started
Nov 11, 2024
primary completion
Jul 15, 2025
completion
Jul 15, 2025
last updated
Aug 15, 2025
official title
A PHASE 1/2, RANDOMIZED, OBSERVER-BLINDED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF COMBINED VACCINE CANDIDATES AGAINST INFLUENZA AND COVID-19 IN HEALTHY INDIVIDUALS
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol